Deerfield Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.19M | Buy |
613,665
+163,665
| +36% | +$2.45M | 0.17% | 67 |
|
|
2025
Q1 | $7.26M | Hold |
450,000
| – | – | 0.14% | 74 |
|
|
2024
Q4 | $10.5M | Buy |
+450,000
| New | +$10.5M | 0.2% | 62 |
|
|
2020
Q3 | – | Sell |
-33,000
| Closed | -$7.63M | – | 114 |
|
|
2020
Q2 | $7.63M | Buy |
+33,000
| New | +$7.63M | 0.22% | 81 |
|
|
2019
Q4 | – | Sell |
-20,002
| Closed | -$3.85M | – | 92 |
|
|
2019
Q3 | $3.85M | Hold |
20,002
| – | – | 0.16% | 76 |
|
|
2019
Q2 | $3.43M | Hold |
20,002
| – | – | 0.12% | 86 |
|
|
2019
Q1 | $4.03M | Buy |
+20,002
| New | +$4.03M | 0.15% | 76 |
|